Hoch Lynelle 4
Research Summary
AI-generated summary
Bristol Myers (BMY) — Lynelle Hoch Receives Awarded Shares; Tax Withheld
What Happened
Lynelle Hoch, President of the Cell Therapy Organization at Bristol Myers Squibb (BMY), had multiple equity awards vest/convert on March 10, 2026. The filing shows conversion/exercise of derivative awards and new awards/grants totaling 24,519 share-equivalents (8,192 shares from conversions + 16,327 shares from grants/awards). To cover tax withholding, 1,391 shares were surrendered at $60.13 per share, producing proceeds/coverage of $83,642. All acquisition entries were at $0 per share (they are settlements of equity awards, not open-market purchases).
Key Details
- Transaction date: March 10, 2026. Form 4 filed March 12, 2026 (appears timely).
- Tax withholding: 1,391 shares withheld at $60.13 = $83,642 total. (Filing shows three withholding entries: 212, 267, 912 shares.)
- Award/conversion totals shown: conversions (M) = 8,192 shares; awards/grants (A) = 16,327 shares; “other” zero-value adjustments (J) = 3,302 shares (performance/adjustment-related).
- Shares owned after transaction: not disclosed in the excerpt.
- Notable footnotes: vesting of quarterly market share units from March 10, 2022 and March 10, 2023 (F1, F4); performance share/unit payout and timing (F8, F10, F11); downward adjustments based on performance factors and payout formulas (F2, F6, F7, F9); F3 denotes shares withheld for taxes.
- Filing contains no indication of an open-market sale by the insider—only award settlements and tax withholding.
Context/How to read this
- Codes: M = exercise/conversion of derivative awards (here, settlement of market share units / performance units), A = award/grant, F = shares withheld for taxes, J = other acquisition/disposition or adjustment.
- These transactions reflect compensation-plan settlements (vesting and performance-based conversions), not a discretionary market buy or sell that would necessarily signal a change in personal market view. The tax-withholding was handled by surrendering shares (common “cashless” withholding), not by a public sale of additional shares by the insider.
- No late-filing flag is shown; the Form 4 was filed two days after the transactions, which is typical/timely under SEC rules.